From Wikipedia, the free encyclopedia
Content deleted Content added
|
 |
|||
| Line 1: | Line 1: | ||
|
Nicholas ( |
Nicholas () Finer is an academic clinician and a leading opinion in the field of clinical obesity. He has held consultant appointments at Luton and Dunstable Hospital where he founded the Centre of Obesity Research, undertaking clinical trials of early anti-obesity medications as well as investigator-led projects spanning endocrinology and body composition, and initiating one of the first UK multi-disciplinary bariatric surgery services within the National Health Service. |
||
|
As Senior Clinical Research Associate at Cambridge University and Honorary Consultant Physician at [[Addenbrooke’s Hospital|Addenbrooke’s Hospital]]<nowiki/>s (2002-2009) he established a tertiary centre for obesity assessment and management; he was also clinical director of the Wellcome Clinical Research Facility. In 2008 he was Visiting Professor, Institute of Nutrition Obesity and Exercise. University of Sydney. |
As Senior Clinical Research Associate at Cambridge University and Honorary Consultant Physician at [[Addenbrooke’s Hospital|Addenbrooke’s Hospital]]<nowiki/>s (2002-2009) he established a tertiary centre for obesity assessment and management; he was also clinical director of the Wellcome Clinical Research Facility. In 2008 he was Visiting Professor, Institute of Nutrition Obesity and Exercise. University of Sydney. |
||
|
From 2009-2016 he moved to become Consultant Endocrinologist and Bariatric Physician at [[University College Hospital]], London and Honorary Clinical Professor at the National Centre for Cardiovascular Prevention and Outcomes, UCL Institute of Cardiovascular Science until 2022. From 2016-2022 Nick was Senior Principal Clinical Scientist, Global Medical Affairs, with [[Novo Nordisk]] in Denmark. |
From 2009-2016 he moved to become Consultant Endocrinologist and Bariatric Physician at [[University College Hospital]], London and Honorary Clinical Professor at the National Centre for Cardiovascular Prevention and Outcomes, UCL Institute of Cardiovascular Science until 2022. From 2016-2022 Nick was Senior Principal Clinical Scientist, Global Medical Affairs, with [[Novo Nordisk]] in Denmark. |
||
Latest revision as of 12:03, 29 November 2025
Nicholas (Nick) Finer is an academic clinician and a leading opinion in the field of clinical obesity. He has held consultant appointments at Luton and Dunstable Hospital where he founded the Centre of Obesity Research, undertaking clinical trials of early anti-obesity medications as well as investigator-led projects spanning endocrinology and body composition, and initiating one of the first UK multi-disciplinary bariatric surgery services within the National Health Service.
As Senior Clinical Research Associate at Cambridge University and Honorary Consultant Physician at Addenbrooke’s Hospitals (2002-2009) he established a tertiary centre for obesity assessment and management; he was also clinical director of the Wellcome Clinical Research Facility. In 2008 he was Visiting Professor, Institute of Nutrition Obesity and Exercise. University of Sydney.
From 2009-2016 he moved to become Consultant Endocrinologist and Bariatric Physician at University College Hospital, London and Honorary Clinical Professor at the National Centre for Cardiovascular Prevention and Outcomes, UCL Institute of Cardiovascular Science until 2022. From 2016-2022 Nick was Senior Principal Clinical Scientist, Global Medical Affairs, with Novo Nordisk in Denmark.
Nick’s research on obesity and its related complications is represented by more than 200 peer-reviewed papers and 23 book chapters.https://orcid.org/0000-0003-2468-6804; https://nickfiner2025.mobirisesite.com/
Nick is past Chair of the UK Association for the Study of Obesity and World Obesity Federation Clinical Care, where amongst other roles he was responsible for developing the SCOPE educational programme; he has held positions with the UK Government Advisory Group on Obesity, NICE Public Health Advisory Group, European Association for the Study of Obesity, and the European Society of Hypertension. Nick was the founding Editor-in-Chief of Clinical Obesity from 2011-2022. He received the Bisset Hawkins Medal, a triennial award ‘for work in advancing sanitary science or in promoting public health’, and in 2024 the World Obesity Willendorf Prize.
Currently Nick holds positions as:
• President of the International Prader Willi Syndrome Association
• Chair, World Obesity Publications Committee
• Associate of the Public Health Action Support Team CIC (PHAST)
